Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Int J Med Microbiol. 2016 Nov 4;306(8):595–603. doi: 10.1016/j.ijmm.2016.10.005

Adaptation of Escherichia coli Traversing From the Faecal Environment to the Urinary Tract

Karen L Nielsen a,b,*,, Marc Stegger a, Paul A Godfrey c, Michael Feldgarden c,§, Paal S Andersen a, Niels Frimodt-Møller b,
PMCID: PMC5209455  NIHMSID: NIHMS828369  PMID: 27825516

Abstract

The majority of extraintestinal pathogenic Escherichia coli (ExPEC) causing urinary tract infections (UTI) are found in the patient's own gut flora, but only limited knowledge is available on the potential adaptation that may occur in the bacteria for them to traverse the perineum and successfully infect the urinary tract. Here, matching faecal and UTI isolates from 42 patients were compared pairwise using in-depth whole-genome sequencing to investigate whether genetic changes were evident for successful colonization in these two different environments. The identified non-synonymous mutations (0-12 substitutions in each pair) were primarily associated to genes encoding virulence factors and nutrient metabolism; and indications of parallel evolution were observed in genes encoding the major phase-variable protein antigen 43, a toxin/antitoxin locus and haemolysin B. No differences in virulence potential were observed in a mouse UTI model for five matching faecal and UTI isolates with or without mutations in antigen 43 and haemolysin B. Variations in plasmid content were observed in only four of the 42 pairs. Although, we observed mutations in known UTI virulence genes for a few pairs, the majority showed no detectable differences in mutations or mobilome changes when compared to their faecal counterpart. The results show that UPECs are successful in colonizing both the bladder and gut without adaptation.

Keywords: urinary tract infection, whole genome sequencing, evolution, faecal flora, single-nucleotide polymorphisms, mutations

Introduction

Symptomatic urinary tract infections (UTIs) are particularly common among women and one in three women have, at the age of 24, been diagnosed with UTI (Foxman, 2003). Extraintestinal pathogenic Escherichia coli (ExPEC) are the major cause of UTI, being responsible for up to 80% of all community-acquired UTIs and more than 30% of all nosocomial UTIs (Bouza et al., 2001; Kahlmeter, 2000).

The infecting urinary E. coli is in the majority of the cases found in the patient's own gut flora, indicating a faecal-perineal-urethral route of transmission to the bladder (Yamamoto et al., 1997). Comparisons between Uropathogenic and commensal E. coli, which do not normally cause infections, have identified associations between the presence of certain genes and ecotypes, but also revealed that isolates from the same infection type exhibit large genomic flexibility (Chattopadhyay et al., 2009). Generally, UPEC are associated with phylogenetic group B2, and to a smaller extent D, and are found to carry more virulence factors than commensal isolates which generally are associated with phylogenetic groups A and B1 (Johnson and Russo, 2002; Moreno et al., 2006; Picard et al., 1999; Zhang et al., 2002). Recent studies have, however, shown that healthy women who have never had a UTI carry a large proportion of B2 in their gut flora (Nielsen et al., 2014a), and that these isolates are able to cause infection in a mouse UTI model (Nielsen et al., 2014b).

Successful colonization in two diverse environments, such as the gut and the urinary tract could require highly specific gene repertories or gene variants and possibly involve adaptive mutations and acquisition of genetic elements when migrating between environments (Orr and Smith, 1998). Acquisition of mobile genetic elements can affect the fitness of the bacteria, which can lead to selection of more fit sub-lineages (Nielsen et al., 2012; Subbiah et al., 2011). Similarly, point mutations can result in significant adaptive effects and provide rapid adaptation to specific niches (Chattopadhyay et al., 2009; Weissman et al., 2007). The genes in the core genome have generally not been considered significant for the adaptive evolution of the pathogen. However, it has been found that more than 1/3 of the core genes in E. coli are targeted by repeated substitutions in hot-spot positions driven by positive selection (Chattopadhyay et al., 2009), including genes encoding DNA metabolism, nutrient acquisition, cell surface structure and metal-binding (Chattopadhyay et al., 2009; Chen et al., 2009). Mutations that increase fitness in the urinary tract are likely to be selected in the urinary tract (Chen et al., 2009) and increased fitness in the urinary tract has been correlated to lower fitness in the faecal habitat and it has therefore been proposed that isolates colonizing the urinary tract run into an evolutionary dead-end (source-sink) (Chattopadhyay et al., 2007; Sokurenko et al., 2006). Recently, Chen et al. (Chen et al., 2013) whole-genome sequenced matching UTI and faecal isolates from two patients and identified that the same strain was present in both urine and faecal samples in all samplings of one of the patients, when studying paired urine and faecal isolates over time at successive UTIs. For the other patient, different faecal and urinary strains were identified, perhaps indicating that adaptation to the urinary tract is not an evolutionary dead-end (Chen et al., 2013).

As gene acquisitions and the occurrence of mutations that provide adaptive traits are variable in nature and limited between faecal and the urinary tract, larger strain collections are needed to detect these. Understanding the adaptation of the E. coli genome and genes under selection are important key components to understand the mechanisms of UTI pathogenesis. In this genome-based approach we analyzed a large collection of paired faecal and urinary isolates to identify potential adaptation of the UTI E. coli compared to the faecal counterpart. In total, 42 E. coli pairs from faeces and urine were characterized with respect to point mutations, phage and plasmid content in order to identify adaptive traits.

Methods

Study Participants

The study was approved by The Danish National Committee on Biomedical Research Ethics and the Danish Data Protection Agency. The study included adult participants only, and informed written consent was obtained for all participants prior to participation.

Isolates in this study have been described in detail by Nielsen et al. (Nielsen et al., 2014a). Briefly, we recruited otherwise healthy women with UTI from their own general practitioner in Zealand, Denmark. All participants delivered a urine sample and a faecal swab on the day of inclusion. Inclusion criteria: UTI symptoms, and having ≥104 E. coli/mL and leucocytes in the urine sample.

Bacterial Isolates

From the collection of faecal and urinary isolates we analysed the genomes of 45 faecal and urinary pairs with matching RAPD profile as described by Nielsen et al. (Nielsen et al., 2014a). Classification of the isolates into the four phylogroups (A, B1, B2, D) and non-typeables (NT) was performed using the multiplex PCR of Clermont et al. (Clermont et al., 2000), with an additional PCR for ibeA, as recommended by Gordon et al. (Gordon et al., 2008), as previously described (Nielsen et al., 2014a).

Sequencing, Assembly and Annotation

Total DNA was purified using DNeasy Blood and Tissue kit (Qiagen), following manufacturer's instructions. All isolates were subject to whole genome sequencing on HiSeq 2000 (Illumina). The UTI isolates were sequenced using both 180 bp fragment libraries and 3 kb mate-pair libraries, as previously described (Grad et al., 2012). Forty-five faecal isolates with similar RAPD and identical phylogroup to the UPEC isolate of the same patient were sequenced using 180 bp fragment libraries produced as previously described (Grad et al., 2012).

The assemblies were performed using ALLPATHS-LG and gene contents were determined for all genomes using Prodigal (Grad et al., 2012). Briefly, annotations were based on BLAST hits against the Swiss-Prot protein database (≥70% identity and ≥70% query coverage), TIGRfam, HMMER, and Pfam. The gene content was grouped into orthologous clusters across the complete set of genomes using Reciprocal best hit BLAST. Core genes were defined as at least one copy in the genomes of all included isolates, auxiliary genes were defined as missing from the genome of at least one isolate.

Phylogenetics and Typing

Phylogenetic reconstruction was performed using FastTree (Price et al., 2009) on phylogenetic informative sites in 3083 single copy core genes of all 90 isolates. This was identified by Reciprocal best hit BLAST and single linkage clustering. MLST types and serotypes were determined using MLST 1.8 (Larsen et al., 2012) and SeroTypeFinder 1.1 (Joensen et al., 2015), respectively (http://www.genomicepidemiology.org/).

Mutations

Mutations were identified by pairwise single nucleotide polymorphism (SNP) calls for each of the 45 RAPD pairs. The UTI isolates were chosen as reference as their genomes were assembled using a combination of paired-end and mate-pair libraries, producing a higher quality draft genome with respect to sequencing depth and scaffold counts. We aligned reads of the faecal isolates against the matching UTI genome using BWA (Li and Durbin, 2009) with identification of SNPs using GATK (Mckenna et al., 2010), with the following criteria: >90% agreement among reads, ≥5 unambiguously mapped reads, ≤50% mapping ambiguity. Raw variant call format (VCF) files were annotated using VCFannotator (http://vcfannotator.sourceforge.net). Insertions/deletions were ignored. SNPs in or adjacent to structural phage proteins and transposases were ignored due to the potential presence of multiple copies across the genome. Mutations were verified by manual inspection of the de novo assembly of the UTI genome itself and against the genome of its paired faecal isolate.

Mobilome analyses

Phage content of each isolate was determined applying the PHAST database (Zhou et al., 2011) with a cut-off value of 60% similarity. The sequences of all phages were identified in the concatenated genomes of both urinary and faecal isolates, and Illumina reads of the matching isolate were mapped towards these regions to confirm loss/gain between matching isolates.

A plasmid BLAST database that included all complete E. coli plasmids (N=287) found at NCBI (database created March 2014) was used to identify possible plasmids in the sequenced isolates. A BLAST search was performed with each plasmid against the 90 concatenated genomes with >80% identity as cut-off value. The results were verified by individual reference mapping of the respective paired-end reads against the plasmid sequence for both isolates in a pair. The isolates were considered to carry identical plasmids when the reference mappings were indistinguishable.

in vivo Virulence

The experiments were permitted by the Animal Experiments Inspectorate under the Danish Ministry of Food, Agriculture and Fisheries. The in vivo virulence was investigated in a mouse UTI model (Hvidberg et al., 2000; Jakobsen et al., 2011) with five faecal/UTI pairs: Pair #1, #3, #11, #18 and #39. Briefly, mouse bladders were emptied prior to transurethral inoculation with 50 μl of bacterial suspension (109 CFU/ml). Each E. coli isolate was inoculated into eight outbred female albino OF1 mice (28 to 32 g; Charles River Laboratories). For the faecal and UTI isolate of pair #39 it was only possible to inoculate 6 and 7 mice, respectively. Urine was collected 72 hrs. post inoculation and mice were euthanized by cervical dislocation, followed by removal of the bladder and kidneys. Bacterial counts were determined for urine, bladder, and kidneys. Urine samples were processed on the same day, whereas kidneys and bladders were stored in 0.9% saline solution at −80°C until processed. The detection limit was 25 CFU/ml.

Results

Samples and Matching Pairs

Forty-five matching UTI and faecal E. coli pairs from 45 patients were identified and compared by RAPD PCR as previously described (Nielsen et al., 2014a). The isolates were subsequently whole genome sequenced. Phylogenetic analyses, based on 3083 single copy core genes revealed that 42 of these were identical pairs, and three pairs differed significantly in their core content (marked with red, orange and yellow squares, respectively; Fig 1). Analyses revealed that the non-matching UTI isolates and their expected faecal counterparts differed by 28,599 (pair #26), 38,351 (pair #45) and 100,716 (pair #6) SNPs, respectively. These were excluded from further analyses. The phylogenetic comparison of the pairs indicated that RAPD PCR was successful in pairing the faecal and UTI isolates (error rate of 6.7%). The 42 matching pairs belonged to phylotypes A (n=3), B1 (n=1), B2 (n=26), D (n=11) and NT (n=1) respectively. Serotypes and MLST types were determined (Suplementary table S2).

Fig 1.

Fig 1

Core content phylogeny (3083 genes) of 45 RAPD pairs. Colored squares indicate non-matching isolates.

Number of Mutations between Pairs

For the remaining 42 pairs, we identified a total of 409 coding (n=265) and non-coding (n=144) mutations with a range of 1-31 (0-8 non-coding and 1-25 coding) between the pairs (Table 1, supplementary figure S1). Overall, 107 non-synonymous (NSY) mutations, with a range of 0-12 in each pair, were identified (complete list of NSY in supplementary table S3). A substantial part of these were positioned in hypothetical proteins (n=42) to which no function had been assigned (Table S3). Eight pairs had no NSY mutations.

Table 1.

Number of mutations in the 42 pairs

Pair ID Total mutations* N=409 Non-coding> N=144 Coding
Total N=265 NSY§ N=107 SYN N=158
1 20 3 17 8 9
2 22 5 17 7 10
3 10 3 7 4 3
4 1 0 1 0 1
5 9 3 6 3 3
7 3 0 3 0 3
8 5 2 3 0 3
9 15 5 10 3 7
10 10 3 7 1 6
11 31 6 25 12 13
12 6 3 3 1 2
13 13 4 9 5 4
14 5 1 4 1 3
15 7 5 2 0 2
16 15 5 10 3 7
17 11 6 5 3 2
18 15 4 11 3 8
19 7 2 5 0 5
20 10 2 8 2 6
21 6 2 4 2 2
22 10 8 2 1 1
23 9 4 5 3 2
24 7 6 1 0 1
25 9 3 6 3 3
27 8 4 4 3 1
28 23 3 20 5 15
29 6 1 5 0 5
30 7 2 5 2 3
31 5 2 3 2 1
32 6 4 2 1 1
33 9 3 6 5 1
34 9 6 3 2 1
35 7 4 3 1 2
36 7 3 4 2 2
37 5 1 4 4 0
38 10 4 6 3 3
39 8 3 5 2 3
40 14 8 6 2 4
41 8 2 6 1 5
42 9 3 6 4 2
43 6 2 4 3 1
44 6 4 2 0 2
*

The total number of mutations was defined as all mutations identified excluding those in SNPs in structural phage proteins, transposases as well as insertions/deletions.

§

NSY: Non-synonymous mutations

SYN: synonymous mutations

Mutation analyses identified 256 intergenic mutations within the fim-switch in 11 pairs which were not included in this table.

The analyses identified 256 intergenic mutations across 11 pairs in the fim switch (excluded from the number of non-coding mutations in Table 1), responsible for regulation of type 1 fimbrial expression by inversion of a DNA fragment flanked by inverted repeats (Gally et al., 1996, 1994). The orientation of this fragment determines the transcription of the fimbrial genes, hence fimbriation, in an on/off manner. It is assumed that these mutations are not true polymorphisms, but due to the inverted repeats, hence, the exclusion.

As isolates of phylotype B2 and D are the most common phylotypes in UTI, one could hypothesize that isolates of these phylotypes were more readily prepared to the urinary environment. This hypothesis assumed that the mutations were selective rather than random. However, we observed no correlation between phylotype of the isolates and number of mutations in the individual pairs; the three pairs with the highest and lowest number of mutations belonged to phylotype B2 and D (data not shown).

Genes with Non-synonymous Mutations

In the 42 pairs, we identified 24 NSY mutations in UTI and virulence-associated genes (Table 2). Three of the 42 pairs had variations in antigen 43 (ag43) (a total of four mutations), and were positioned in the region encoding the α-domain (n=3) or β-domain (n=1) associated to aggregation and membrane-association, respectively. Additionally, we identified five mutations in total across three pairs of isolates in the yee-locus controlling cell growth and death under stress conditions (Masuda et al., 2012); two isolates had one mutation in toxin yeeV, and one isolate had three mutations in antitoxin yeeU (Table 2). Two pairs each had one mutation in hlyB responsible for haemolysin transport out of the cell (Cross et al., 1990; Hughes et al., 1983) (Table 2). Finally, UTI-faecal pair #3 was observed to have three NSY mutations in the sfaH gene encoding an S-fimbrial subunit.

Table 2.

Non-synonymous mutations in genes associated with virulence or UTI.

Pair ID Gene Position* Amino acid Substitution
11 antigen 43 1382:aTc-aCc Ile-461-Thr
18 antigen 43 2603:cAg-cTg Gln-868-Leu
1 antigen 43 923:cTg-cAg Leu-308-Gln
1 antigen 43 974:aTa-aCa Ile-325-Thr
17 antitoxin YeeU 43:Cac-Gac His-15-Asp
17 antitoxin YeeU 50:cGc-cAc Arg-17-His
17 antitoxin YeeU 82:Tcc-Ccc Ser-28-Pro
25 toxin YeeV 215:cAg-cTg Gln-72-Leu
23 toxin YeeV 130:Tcc-Gcc Ser-44-Ala
28 Fe(3+) dicitrate transport system permease fecD 398:cCc-cAc Pro-133-His
33 filamentous hemagglutinin family domain-containing protein 667:Ata-Gta, Ile-223-Val
39 flagellar motor switch protein FliN 268:Gac-Aac Asp-90-Asn
3 haemolysin activator HlyB 1016:cGg-cTg Arg-339-Leu
39 haemolysin activator HlyB 277:Gtg-Atg Val-93-Met
28 protein rhsB 1549:Ttc-Ctc Phe-517-Leu
28 protein rhsC 1180:Gac-Aac Asp-394-Asn
21 rhs element Vgr protein 721:Tcc-Acc Ser-241-Thr
11 regulator PapX protein 308:aCg-aTg Thr-103-Met
3 S-fimbrial protein subunit SfaH 763:Gca-Aca Ala-255-Thr
3 S-fimbrial protein subunit SfaH 772:Tct-Gct Ser-258-Ala
3 S-fimbrial protein subunit SfaH 787:Ata-Gta Ile-263-Val
33 TonB-dependent heme/hemoglobin receptor family protein 161:gAt-gCt Asp-54-Ala
11 type 1 fimbriae regulatory protein fimE 48:atA-atG Ile-16-Met
16 type VI secretion protein 1454:cCc-cAc Pro-485-His
*

Capital letters indicate nucleotide substitution

FimH has been described to have UTI specific adaptive mutations (Hommais et al., 2003; Sokurenko et al., 1998); however, we did not identify any such mutations in the current study.

Mutations in metabolism genes were also observed among the 42 pairs (Table 3). These were mainly observed in genes encoding enzymes relevant for nutritional acquisition. With respect to the local environment surrounding the bacteria, we observed one NSY mutation in cold-shock protein, CspE, as well as a premature stop codon in the gene encoding a protein involved in acid resistance (YdeP) (Table 3). The sequence downstream of the truncated ydeP belongs to IS element 1 (insA and insB) (Escoubas et al., 1994), indicating insertion of a mobile element as cause of gene disruption.

Table 3.

Non-synonymous mutations in genes related to nutrient acquisition and local environment.

Pair ID Gene Position* Amino acid Substitution
1 GTPase 524:gCa-gAa Ala-175-Glu
1 L-xylulose/3-keto-L-gulonate kinase 65:cAc-cGc His-22-Arg
2 taurine-binding periplasmic protein 523:Gtc-Atc Val-175-Ile
5 protein CsiD 718:Gtg-Atg Val-240-Met
11 cold shock-like protein CspE 179:gGc-gAc Gly-60-Asp
11 periplasmic AppA protein 125:cGt-cAt Arg-42-His
11 D-tagatose-1,6-bisphosphate aldolase subunit kbaZ 169:Ggc-Agc Gly-57-Ser
11 PTS system protein 761:tAt-tGt Tyr-254-Cys
11 protein ydeP 2239:Tga-Cga STP-747-Arg
20 dihydrolipoyl dehydrogenase 1124:gAa-gCa Glu-375-Ala
22 carboxysome structural protein, ethanolamine utilization 271:Aaa-Taa Lys-91-STP
23 carbamate kinase 328:Cag-Gag Gln-110-Glu
23 inner membrane protein 1894:Tca-Cca Ser-632-Pro
27 maltodextrin phosphorylase 791:gTc-gCc Val-264-Ala
28 Phosphomannomutase 661:Att-Gtt Ile-221-Val
31 maltose regulon periplasmic protein 653:tCg-tTg Ser-218-Leu
32 tautomerase ppt 176:gAa-gCa Glu-59-Ala
33 GTPase 784:Gtt-Att Val-262-Ile
33 oxygen-insensitive NADPH nitroreductase 214:Taa-Caa STP-72-Gln
34 Phosphomannomutase 880:Gtt-Att Val-294-Ile
37 phospho-2-dehydro-3-deoxyheptonate aldolase, Tyr-sensitive 198:gaA-gaT Glu-66-Asp
37 carbon storage regulator 34:Ttc-Ctc Phe-12-Leu
37 carbon storage regulator 32:aCc-aTc Thr-11-Ile
37 undecaprenyl-phosphate galactose phosphotransferase WbaP 238:Gaa-Taa Glu-80-STP
40 Ecotin 56:tTg-tGg Leu-19-Trp
42 serine/threonine-protein phosphatase 1 126:gaT-gaA Asp-42-Glu
42 inorganic phosphate transporter 1 1265:cAg-cCg Gln-422-Pro
43 ribosomal RNA large subunit methyltransferase L 664:Tgt-Cgt Cys-222-Arg
*

Capital letters indicate the codon position of the mutation

STP: Stop codon

Phages

The phage content was studied for the 42 paired isolates, in order to identify any changes between the matching isolates. Overall, we found identical phage content between the pairs, with only minor differences in three phages between the pairs (pair #5, 12, and 21). Pair #5 had an additional gene (host factor gene) in the urine isolate compared to the faecal isolate (1788 bp). Pair #12 had two additional open reading frames (hypothetical) in a single phage in the urine isolate, compared to the faecal isolate (1170 bp). Finally, pair #21 had an additional fragment (phage tail fiber proteins 07) compared to the faecal isolate (3021bp).

Plasmids

Plasmid contents of the 84 isolates were determined. Two UTI isolates had lost a plasmid, and two UTI isolates had gained a plasmid, compared to the faecal clone. We expect that the uptake of plasmids has occurred in the faecal environment, before traversion to the urinary tract. The plasmid lost by pair #1 was a small plasmid with no virulence or antimicrobial resistance genes predicted from the annotation (identical to GenBank ID DQ995352). Pair #40 had lost a plasmid highly similar to plasmid pHUSEC41-1 (GenBank ID HE603110) (only differences in a rep gene and a gene encoding a transposase). This plasmid, encoding e.g. aminoglycoside, streptomycin and β-lactam resistance, was characterized in the hemolytic uretic syndrome outbreak in Germany in 2011 (Künne et al., 2012). The additional plasmid in the UTI isolate from pair #5 was similar to plasmid pUM146 (GenBank ID CP002168.1), which contains putative virulence-associated factors, such as type IV secretion, iron uptake systems, and antimicrobial peptide transport. Finally, the UTI isolate of pair ID #26 had an additional plasmid compared to the faecal isolate, which was highly similar to plasmid sP1400_89 described in Salmonella enteria Enteritidis, increasing its invasiveness and promoting growth of the bacteria (Coward et al. unpublished, GenBank ID JN796410.1).

in vivo Virulence

In order to evaluate the in vivo virulence potential of both urine and faecal isolates we performed mouse UTI model studies of five pairs: UTI and faecal isolates of three pairs with antigen 43 mutations and two pairs with HlyB mutations (Fig. 2a and 2b, respectively). We performed in vivo virulence experiments on these isolates, as we found more than one pair with mutations in these genes in addition to the SNPs being positioned in UTI relevant genes (Cross et al., 1990; Ejrnæs et al., 2011; Hughes et al., 1983). The results showed no detectable difference in in vivo virulence in pairs when comparing the faecal isolate to the UTI counterpart, except for one pair, #39 (a HlyB mutant), where we observed lower CFU counts in urine for the UTI isolate compared to the faecal isolate (Fig. 2a). There was, however, no difference in CFU levels of bladder and kidneys for pair #39 (Fig. 2a).

Fig. 2.

Fig. 2

in vivo virulence of selected pairs with non-synonymous mutations. Left column: Pair ID #3 and #39 with HlyB mutations, CFU count in urine (a), bladder (b) and kidneys (c). Right column: Pair ID #11, #18 and #1, all containing mutations in antigen 43, CFU count in urine (d), bladder (e) and kidneys (f). Closed circles: Faecal isolates, open circles: UTI isolates. The mutations between the isolates did no infect the in vivo virulence, a part from #39 where the faecal isolate caused higher CFU levels with the faeces isolate compared to the urine isolate (a).

Discussion

The present study is the first to compare a large collection of matching faecal and UTI E. coli isolates from the same patients by whole genome sequencing. The genomes and resulting scaffolds were of excellent quality due to the mate-pair sequencing of the UTI isolates, enabling us to do in depth genome analyses with a reliable outcome (supplementary table S1). Overall the pairs were highly similar. However, noteworthy in this study, variations, which distinguish the UTI isolate from its corresponding faecal counterpart were identified, including mutations in virulence associated, nutrient- and DNA-metabolism genes as well as uptake of plasmids. These changes could potentially have occurred en route from the faecal and nutrition rich environment to the urinary tract.

We identified NSY mutations in a number of proteins that serve functions in (1) biofilm formation (ag43), which is an important feature of UTI isolates; (2) in SfaH, necessary for the formation of S-fimbria important for adhesion during urinary tract infection (Herías et al., 2001; Kreft et al., 1995; Schmoll et al., 1989); (3) in HlyB, responsible for export of α-haemolysin (a UTI virulence factor); (4) in cold-shock and acid resistance proteins (CspE and YdeP), possibly involved in adapting to environmental change were also found in a few pairs; and finally, (5) in the Yee proteins encoding a toxin / antitoxin pair. All of the genes with mutations in more than one pair are thought important for UTI development: The yee-locus has previously been described to be under positive selection in virulent E. coli (Brown and Shaw, 2003; McNally et al., 2013; Petersen et al., 2007), α-haemolysin expression has very recently been shown to be involved in UPEC fitness (Nagamatsu et al., 2015) and finally, ag43 has been correlated to UTI virulence (Ejrnæs et al., 2011; Ulett et al., 2007).

The mutation rate of wild type E. coli is approximately 10−3 per genome per generation (Lee et al., 2012). For some UPEC, this has been shown to be 100-1000 fold greater (Lee et al., 2012), and mutator strains may be correlated to persistent UTI infections (Denamur and Matic, 2006). Based on the number of identified mutations, we do not suspect any hyper-mutators among the 42 pairs. The study included one isolate from the faecal and urinary samples, respectively. Taken into account possible intra-clonal variation, the observed number of mutations between the two environments is likely to be even smaller than represented here. Therefore the range of total mutations in this study demonstrates that movement to the urinary tract in most instances required no or very few mutations based on 42 paired isolates. The observed mutations could be of either adaptive or random nature, although the authors consider it highly unlikely that, more than one pair had mutations in the same gene (as was the case for ag43, hlyB and the yee-locus) if this gene was not under selection.

ag43 was a hotspot for variation as we identified four mutations in three pairs. ag43 has previously been shown to be correlated to UTI virulence and biofilm production (Anderson et al., 2003; Danese et al., 2000; Ejrnæs et al., 2011; Henderson et al., 1997; Ulett et al., 2007). Three of the variations identified in this study are situated in the α-domain of the molecule; the domain responsible for the actual aggregation (Heras et al., 2013), whereas the last mutation is present in the β-domain that forms the outer membrane protein (Hasman et al., 1999). The crystal structure of ag43 has recently been resolved, revealing details regarding the aggregation (Heras et al., 2013). The aggregation is caused by self-aggregation of α-domains by hydrogen bonds between the molecules. One of the identified mutations is a neighboring amino acid to one of these hydrogen bonds, suggesting that this amino acid change could influence aggregation. The in vivo investigation of UTI virulence of ag43 mutants in a mouse UTI model did not show detectable differences in virulence potential despite ag43 mutations. This indicates (i) that genes with these mutations are selected for although they do not directly influence the in vivo virulence potential in the used UTI mouse model or (ii) that the difference in virulence was lower than the sensitivity of the model.

As we observed no adaptation in FimH on the route of transmission, as has been described elsewhere (Hommais et al., 2003; Ronald et al., 2008), we expect that such polymorphisms do not occur on the route of transmission to the bladder or in the bladder, but rather in the intestinal tract. Chen et al. (Chen et al., 2013) identified fitness variations to be correlated to differences in the carbohydrate and amino acid utilization profiles. The present study on a larger collection of isolates indicates that nutrient acquisition, in some of the same pathways for nutrient acquisition as identified by Chen et al. (Chen et al., 2013), could be adaptive and possibly correlated to fitness improvement. This should be investigated further.

We did not identify any major changes in phage content between the matching isolates. The observed differences in phage content could be due to recombination events in all three isolates. We identified changes in plasmid content for four pairs, hence, approximately 10% of the pairs. Plasmids are often large elements and frequently associated with fitness loss in the host strain (Dahlberg and Chao, 2003), but they are at times essential for survival, e.g. under selection pressure of antibiotics (Subbiah et al., 2011). Pair #40 lost a plasmid with antimicrobial resistance, possibly due to lack of antibiotic selection pressure, as the patient had not received antibiotics within a year of sampling. Alternatively, the patient could have consumed the antimicrobial resistant isolate. The plasmids acquired by two UTI isolates contain putative virulence factors or have been associated to increased virulence in bacteria, and it is therefore possible that the UTI virulence of these isolates were increased compared to the faecal counterpart. The phages and plasmids were not completely assembled, as the genomes were not closed, thus, these results only indicate the level of variation in the mobilome.

Mutations can affect pathogenesis of the isolates. The mutations in this study could have occurred already before the clone colonized the perineum, urethra and bladder, or could also have taken place once the bacterium settled in the bladder. The present study included one isolate from each predicted faecal clone and one UTI isolate, which limits predictions about the within-strain diversity of both the UTI and faecal clone, hence, the observed differences could also be a consequence of simple intra-clonal variation caused by normal genetic drift. The number of mutations identified across the 42 pairs are normally distributed a part from four outliers (20, 22, 23 and 32 mutations, figure S1). As the isolates were randomly picked, the statistics indicate that we would not expect to find any greater variation within faecal clones than what was observed for faecal-UTI pairs in this study.

Whether the observed mutations affect the pathogenesis of the isolates is difficult to demonstrate in vitro and in vivo. The urine counts of pair #39 were significantly higher for the UTI isolate compared to the faecal counterpart. Urine counts often have a higher variation compared to bladder and kidney counts, due to the often very sparse sample material. As there was no difference in bladder and kidney counts for this pair, it is assumed that the difference observed in urine is a sampling error rather than a true difference.

Numerous genes are involved in e.g. biofilm formation and adhesion and none of the identified ag43 mutations were nonsense mutations leading to e.g. premature stop codons. Overall, the in vivo study revealed no differences in virulence. This could be due to the detection limit of such a model, or on the other hand the pathogenesis was not necessarily affected significantly by the mutations, rather just illustrate a genetic drift of the isolate. As the mutations were not nonsense mutations, did not include mutations at identical positions across the pairs indicating adaptation and the mutations investigated in the mouse UTI model showed no detectable difference in virulence, we assume the effect on pathogenesis to be below the sensitivity of in vitro and in vivo models.

Conclusion

Taken together, the 42 UTI isolates were generally highly similar to the faecal clones with respect to point mutations, phage- and plasmid-content, suggesting that the bacteria were fit to colonize both bladder and gut without major adaptation. However, we find interesting signs of adaptations in a few pairs without detecting different in vivo UTI virulence of those investigated in a mouse UTI model. UTI seems to develop due to exposure to an E. coli fit for both the faecal and urinary environment as well as due to host specific factors, including individual immune status and host behavioral factors.

Supplementary Material

1
2
3
sup1

Acknowledgments

The authors would like to thank the medical and technical staff at Haslev Lægecenter and Lægehuset Ellemarksvej for excellent technical assistance and a fruitful collaboration. Jytte M. Andersen, Dorte Truelsen, Leila Borggild and Frederikke Rosenborg are thanked for excellent technical assistance during the animal experiments. This work was a part of PAR (EU FP7-Health-2009-Single-Stage project (grant agreement #241476)). Additionally, the work was supported by the Danish Council for Strategic Research (DanCARD project #09-067075/DSF) and in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No.: HHSN272200900018C. the funding sources had no involvement in study design, data collection, analysis, interpretation or writing of this paper.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Conflict of interest

None to declare

References

  1. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. Intracellular bacterial biofilm-like pods in urinary tract infections. Science. 2003;301:105–7. doi: 10.1126/science.1084550. [DOI] [PubMed] [Google Scholar]
  2. Bouza E, Juan RS, Munoz P, Voss A, Kluytmans J. A European perspective on nosocomial urinary tract infections I . Report on the microbiology workload , etiology and antimicrobial susceptibility (ESGNI-003 study). Clin.Microbiol.Infect. 2001;7:523–531. doi: 10.1046/j.1198-743x.2001.00326.x. [DOI] [PubMed] [Google Scholar]
  3. Brown JM, Shaw KJ. A Novel Family of Escherichia coli Toxin-Antitoxin Gene Pairs. J. Bacteriol. 2003;185:6600–6608. doi: 10.1128/JB.185.22.6600-6608.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chattopadhyay S, Feldgarden M, Weissman SJ, Dykhuizen DE, van Belle G, Sokurenko EV. Haplotype diversity in “source-sink” dynamics of Escherichia coli urovirulence. J. Mol. Evol. 2007;64:204–14. doi: 10.1007/s00239-006-0063-5. [DOI] [PubMed] [Google Scholar]
  5. Chattopadhyay S, Weissman SJ, Minin VN, Russo T. a, Dykhuizen DE, Sokurenko EV. High frequency of hotspot mutations in core genes of Escherichia coli due to short-term positive selection. Proc. Natl. Acad. Sci. U. S. A. 2009;106:12412–7. doi: 10.1073/pnas.0906217106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chen SL, Hung CS, Pinkner JS, Walker JN, Cusumano CK, Li Z, Bouckaert J, Gordon JI, Hultgren SJ. Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding. Proc. Natl. Acad. Sci. U. S. A. 2009;106:22439–44. doi: 10.1073/pnas.0902179106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chen SL, Wu M, Henderson JP, Hooton TM, Hibbing ME, Hultgren SJ, Gordon JI. Genomic Diversity and Fitness of E. coli Strains Recovered from the Intestinal and Urinary Tracts of Women with Recurrent Urinary Tract Infection. Sci. Transl. Med. 2013;5:184ra60–184ra60. doi: 10.1126/scitranslmed.3005497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clermont O, Bonacorsi S, Bingen E. Rapid and Simple Determination of the Escherichia coli Phylogenetic Group. Appl. Environ. Microbiol. 2000;66:4555–4558. doi: 10.1128/aem.66.10.4555-4558.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cross M. a, Koronakis V, Stanley PL, Hughes C. HlyB-dependent secretion of hemolysin by uropathogenic Escherichia coli requires conserved sequences flanking the chromosomal hly determinant. J. Bacteriol. 1990;172:1217–24. doi: 10.1128/jb.172.3.1217-1224.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dahlberg C, Chao L. Amelioration of the cost of conjugative plasmid carriage in Eschericha coli K12. Genetics. 2003;165:1641–9. doi: 10.1093/genetics/165.4.1641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Danese PN, Pratt L. a, Dove SL, Kolter R. The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol. Microbiol. 2000;37:424–32. doi: 10.1046/j.1365-2958.2000.02008.x. [DOI] [PubMed] [Google Scholar]
  12. Denamur E, Matic I. Evolution of mutation rates in bacteria. Mol. Microbiol. 2006;60:820–7. doi: 10.1111/j.1365-2958.2006.05150.x. [DOI] [PubMed] [Google Scholar]
  13. Ejrnæs K, Stegger M, Reisner A, Ferry S, Monsen T, Holm SE, Lundgren B, Frimodt møller N. Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: Phylogenetic groups , virulence factors and biofilm formation. Virulence. 2011;2:528–537. doi: 10.4161/viru.2.6.18189. [DOI] [PubMed] [Google Scholar]
  14. Escoubas JM, Lane D, Chandler M. Is the IS1 Transposase, InsAB’, the Only IS1-Encoded Protein Required for Efficient Transposition? J. Bacteriol. 1994;176:5864–5867. doi: 10.1128/jb.176.18.5864-5867.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis. Mon. 2003;49:53–70. doi: 10.1067/mda.2003.7. [DOI] [PubMed] [Google Scholar]
  16. Gally DL, Leathart J, Blomfield IC. Interaction of FimB and FimE with the fim switch that controls the phase variation of type 1 fimbriae in Escherichia coli K-12. Mol. Microbiol. 1996;21:725–38. doi: 10.1046/j.1365-2958.1996.311388.x. [DOI] [PubMed] [Google Scholar]
  17. Gally DL, Rucker TJ, Blomfield IC. The leucine-responsive regulatory protein binds to the fim switch to control phase variation of type 1 fimbrial expression in Escherichia coli K-12. J. Bacteriol. 1994;176:5665–72. doi: 10.1128/jb.176.18.5665-5672.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gordon DM, Clermont O, Tolley H, Denamur E. Assigning Escherichia coli strains to phylogenetic groups: multi-locus sequence typing versus the PCR triplex method. Environ. Microbiol. 2008;10:2484–96. doi: 10.1111/j.1462-2920.2008.01669.x. [DOI] [PubMed] [Google Scholar]
  19. Grad YH, Lipsitch M, Feldgarden M, Arachchi HM, Cerqueira GC, Fitzgerald M, Godfrey P, Haas BJ, Murphy CI, Russ C, Sykes S, Walker BJ, Wortman JR, Young S, Zeng Q, Abouelleil A, Bochicchio J, Chauvin S, Desmet T, Gujja S, McCowan C, Montmayeur A, Steelman S, Frimodt-Møller J, Petersen AM, Struve C, Krogfelt K. a, Bingen E, Weill F-X, Lander ES, Nusbaum C, Birren BW, Hung DT, Hanage WP. Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011. Proc. Natl. Acad. Sci. U. S. A. 2012;109:3065–70. doi: 10.1073/pnas.1121491109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hasman H, Chakraborty T, Klemm P. Antigen-43-Mediated Autoaggregation of Escherichia coli Is Blocked by Fimbriation. J. Bacteriol. 1999;181:4834–4841. doi: 10.1128/jb.181.16.4834-4841.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Henderson IR, Meehan M, Owen P. Antigen 43, a phase-variable bipartite outer membrane protein, determines colony morphology and autoaggregation in Escherichia coli K-12. FEMS Microbiol. Lett. 1997;149:115–20. doi: 10.1111/j.1574-6968.1997.tb10317.x. [DOI] [PubMed] [Google Scholar]
  22. Heras B, Totsika M, Peters KM, Paxman JJ, Gee CL, Jarrott RJ, Perugini M. a, Whitten AE, Schembri M. a. The antigen 43 structure reveals a molecular Velcro-like mechanism of autotransporter-mediated bacterial clumping. Proc. Natl. Acad. Sci. U. S. A. 2013:1–6. doi: 10.1073/pnas.1311592111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Herías VM, Robertson a K., Midtvedt T, Wold a E. Escherichia coli S fimbriae do not contribute to intestinal colonization or translocation in the gnotobiotic rat. Microb. Pathog. 2001;31:103–7. doi: 10.1006/mpat.2001.0449. [DOI] [PubMed] [Google Scholar]
  24. Hommais F, Gouriou S, Amorin C, Bui H, Rahimy MC, Picard B, Denamur E. The FimH A27V Mutation Is Pathoadaptive for Urovirulence in Escherichia coli B2 Phylogenetic Group Isolates The FimH A27V Mutation Is Pathoadaptive for Urovirulence in Escherichia coli B2 Phylogenetic Group Isolates. Infect. Immun. 2003;71:3619–3622. doi: 10.1128/IAI.71.6.3619-3622.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hughes C, Hacker J, Roberts a, Goebel W. Hemolysin production as a virulence marker in symptomatic and asymptomatic urinary tract infections caused by Escherichia coli. Infect. Immun. 1983;39:546–51. doi: 10.1128/iai.39.2.546-551.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hvidberg H, Struve C, Krogfelt K. a, Christensen N, Rasmussen SN, Frimodt-Møller N. Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies. Antimicrob. Agents Chemother. 2000;44:156–63. doi: 10.1128/aac.44.1.156-163.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Jakobsen L, Garneau P, Bruant G, Harel J, Olsen SS, Porsbo LJ, Hammerum a M., Frimodt-Møller N. Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat. Eur. J. Clin. Microbiol. Infect. Dis. 2011;31:1121–9. doi: 10.1007/s10096-011-1417-5. [DOI] [PubMed] [Google Scholar]
  28. Joensen KG, Tetzschner AM, Iguchi A, Aarestrup FM, Scheutz F. Rapid and easy in silico serotyping of Escherichia coli using whole genome sequencing (WGS) data. J.Clin.Microbiol. 2015;53:2410–2426. doi: 10.1128/JCM.00008-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Johnson JR, Russo T. a. Extraintestinal pathogenic Escherichia coli: “The other bad E coli .”. J. Lab. Clin. Med. 2002;139:155–162. doi: 10.1067/mlc.2002.121550. [DOI] [PubMed] [Google Scholar]
  30. Kahlmeter G. The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens--interim report. J. Antimicrob. Chemother. 2000;46(Suppl 1):15–22. [PubMed] [Google Scholar]
  31. Kreft B, Placzek M, Doehn C, Hacker J, Schmidt G, Wasenauer G, Hacker RG, Kreft B, Placzek M, Doehn C. S fimbriae of uropathogenic Escherichia coli bind to primary human renal proximal tubular epithelial cells but do not induce expression of intercellular adhesion molecule 1. Infect. Immun. 1995;63:3235–3238. doi: 10.1128/iai.63.8.3235-3238.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Künne C, Billion A, Mshana SE, Schmiedel J, Domann E, Hossain H, Hain T, Imirzalioglu C, Chakraborty T. Complete sequences of plasmids from the hemolytic uremic syndrome-associated Escherichia coli strain HUSEC41. J. Bacteriol. 2012;194:532–3. doi: 10.1128/JB.06368-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, Jelsbak L, Sicheritz-Pontén T, Ussery DW, Aarestrup FM, Lund O. Multilocus Sequence Typing of Total Genome Sequenced Bacteria. J. Clin. Micobiol. 2012;50:1355–1361. doi: 10.1128/JCM.06094-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lee H, Popodi E, Tang H, Foster PL. Rate and molecular spectrum of spontaneous mutations in the bacterium Escherichia coli as determined by whole-genome sequencing. Proc. Natl. Acad. Sci. U. S. A. 2012;109:E2774–83. doi: 10.1073/pnas.1210309109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–60. doi: 10.1093/bioinformatics/btp324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Masuda H, Tan Q, Awano N, Wu K-P, Inouye M. YeeU enhances the bundling of cytoskeletal polymers of MreB and FtsZ, antagonizing the CbtA (YeeV) toxicity in Escherichia coli. Mol. Microbiol. 2012;84:979–89. doi: 10.1111/j.1365-2958.2012.08068.x. [DOI] [PubMed] [Google Scholar]
  37. Mckenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, Depristo MA. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–1303. doi: 10.1101/gr.107524.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. McNally A, Alhashash F, Collins M, Alqasim A, Paszckiewicz K, Weston V, Diggle M. Genomic analysis of extra-intestinal pathogenic Escherichia coli urosepsis. Clin. Microbiol. Infect. 2013;19:E328–334. doi: 10.1111/1469-0691.12202. [DOI] [PubMed] [Google Scholar]
  39. Moreno E, Andreu a, Pérez T, Sabaté M, Johnson JR, Prats G. Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts. Epidemiol. Infect. 2006;134:1015–23. doi: 10.1017/S0950268806005917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Nagamatsu K, Hannan TJ, Guest RL, Kostakioti M, Hadjifrangiskou M, Binkley J, Dodson K, Raivio TL, Hultgren SJ. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection. Proc. Natl. Acad. Sci. U. S. A. 2015;112:E871–80. doi: 10.1073/pnas.1500374112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Nielsen KL, Pedersen TM, Udekwu KI, Petersen A, Skov RL, Hansen LH, Hughes D, Frimodt-Møller N. Fitness cost: a bacteriological explanation for the demise of the first international methicillin-resistant Staphylococcus aureus epidemic. J. Antimicrob. Chemother. 2012;67:1325–32. doi: 10.1093/jac/dks051. [DOI] [PubMed] [Google Scholar]
  42. Nielsen KL, Dynesen P, Larsen P, Frimodt-Møller N. Faecal Escherichia coli from patients with E. coli urinary tract infection and healthy controls who have never had a urinary tract infection. J. Med. Microbiol. 2014a;63:582–9. doi: 10.1099/jmm.0.068783-0. [DOI] [PubMed] [Google Scholar]
  43. Nielsen KL, Dynesen P, Larsen P, Jakobsen L, Andersen PS, Frimodt-Møller N. The Role of Urinary Cathelicidin (LL-37) and Human β-defensin 1 (hBD-1) in Uncomplicated Escherichia coli Urinary Tract Infections. Infect. Immun. 2014b;82:1572–1578. doi: 10.1128/IAI.01393-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Orr MR, Smith TB. Ecology and speciation. Trends Ecol. Evol. 1998;13:502–506. doi: 10.1016/s0169-5347(98)01511-0. [DOI] [PubMed] [Google Scholar]
  45. Petersen L, Bollback JP, Dimmic M, Hubisz M, Nielsen R. Genes under positive selection in Escherichia coli. Genome Res. 2007;17:1336–43. doi: 10.1101/gr.6254707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, Bingen E, Denamur E, Garcia S. The Link between Phylogeny and Virulence in Escherichia coli Extraintestinal Infection. Infection. 1999;67:546–553. doi: 10.1128/iai.67.2.546-553.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Price MN, Dehal PS, Arkin AP. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol. Biol. Evol. 2009;26:1641–50. doi: 10.1093/molbev/msp077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Ronald LS, Yakovenko O, Yazvenko N, Chattopadhyay S, Aprikian P, Thomas WE, Sokurenko EV. Adaptive mutations in the signal peptide of the type 1 fimbrial adhesin of uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 2008;105:10937–42. doi: 10.1073/pnas.0803158105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Schmoll T, Hoschützky H, Morschhäuser J, Lottspeich F, Jann K, Hacker J. Analysis of genes coding for the sialic acid-binding adhesin and two other minor fimbrial subunits of the S-fimbrial adhesin determinant of Escherichia coli. Mol. Microbiol. 1989;3:1735–44. doi: 10.1111/j.1365-2958.1989.tb00159.x. [DOI] [PubMed] [Google Scholar]
  50. Sokurenko EV, Chesnokova V, Dykhuizen DE, Ofek I, Wu XR, Krogfelt K. a, Struve C, Schembri M. a, Hasty DL. Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc. Natl. Acad. Sci. U. S. A. 1998;95:8922–6. doi: 10.1073/pnas.95.15.8922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Sokurenko EV, Gomulkiewicz R, Dykhuizen DE. Source-sink dynamics of virulence evolution. Nat. Rev. Microbiol. 2006;4:548–55. doi: 10.1038/nrmicro1446. [DOI] [PubMed] [Google Scholar]
  52. Subbiah M, Top EM, Shah DH, Call DR. Selection pressure required for long-term persistence of blaCMY-2-positive IncA/C plasmids. Appl. Environ. Microbiol. 2011;77:4486–93. doi: 10.1128/AEM.02788-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Ulett GC, Valle J, Beloin C, Sherlock O, Ghigo J-MM, Schembri M. a. Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect. Immun. 2007;75:3233–44. doi: 10.1128/IAI.01952-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Weissman SJ, Beskhlebnaya V, Chesnokova V, Chattopadhyay S, Stamm WE, Hooton TM, Sokurenko EV. Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin. Infect. Immun. 2007;75:3548–55. doi: 10.1128/IAI.01963-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Yamamoto S, Tsukamoto T, Terai a, Kurazono H, Takeda Y, Yoshida O. Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. J. Urol. 1997;157:1127–9. [PubMed] [Google Scholar]
  56. Zhang L, Foxman B, Marrs C. Both Urinary and Rectal Escherichia coli Isolates Are Dominated by Strains of Phylogenetic Group B2. J. Clin. Microbiol. 2002;40:3951–3955. doi: 10.1128/JCM.40.11.3951-3955.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Zhou Y, Liang Y, Lynch KH, Dennis JJ, Wishart DS. PHAST: a fast phage search tool. Nucleic Acids Res. 2011;39:W347–52. doi: 10.1093/nar/gkr485. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1
2
3
sup1

RESOURCES